medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2005, Number 1

<< Back Next >>

Rev Esp Med Quir 2005; 10 (1)

Hacia la prevención de las enfermedades cardiovasculares y de la hipertensión arterial. A partir de la epidemiología de la hipertensión diastólica aislada

Morales RJJ, Angulo PB, Rosas AC, Beauroyre HR, Corro SMÁ

Language: Spanish
References: 19
Page: 53-60
PDF size: 203.98 Kb.


ABSTRACT

Objective. In this of three trails on arterial hypertension, we search3ed for data that will permit the development of preventive strategies, starting from the analysis of prevalence in individuals with isolate diastolic hypertension (PAHAD). Material and methods. We found after studying more than twelve thousand persons at work, home or school that PA-HAD. Results. PA-HAD was: a) the most frequent variety; b) it is mot frequently found un both genders under 15 years old; c) it may related with their physical development, height in this case having a small but significant influence, independent of body mass (OR 1.03, IC 95%, 1,01-1.04); d) risk raises with body mass quintiles being significance from de third quintile on, even though mass body influence is less en PA-HAS (arterial pressure in compatible laves with the criterion of systole and diastolic hypertension; e) it has a prevalence that remains under 15% and tends to diminish in elder groups; f) men have a double risk than women; g) weight control regaining at early ages is the only effective preventive strategy for there was no connection with tabaco or sport; h) It is in this type of hypertensions in which we observe a mayor deference between individuals under go years of age with a without risk factors.
Conclusions. In these three trails the evidence that de types id hypertension are different entities related to different process, with regional variations and with limited possibilities in prevention, being necessary further research.


REFERENCES

  1. Secretaría de Salud. Mortalidad 1998. Contexto actual y aspectos relevantes. Perfiles Estadísticos Nº 13. pp. 37. 1999. México.

  2. Secretaría de Salud. Principales Causas de Mortalidad General 1999. http://www.ssa.gob.mx/unidades/dgied/

  3. Consejo Nacional de Población.- Indicadores Sociodemográficos Proyecciones de Población de México 1996-2050. http://www.conapo.gob.mx/indicaso.

  4. Hoyert DL, Arias E, Smith BL, Murphy SL, Kochanek KD. Deaths: Final Data for 1999. National Vital Statistics Report 2001;49:28.

  5. U.S. Census Bureau. Resident Population Estimates of the United States by Age and Sex: April 1, 1990 to July 1, 1999, with Short-Term Projection to April 1, 2000. Population Estimates Program, Population Division, U.S. Census Bureau, Washington, D.C. 20233. Internet Release Date: May 24, 2000.

  6. Defunciones según la Causa de Muerte 1999. Instituto Nacional de Estadística. España. http://www.ine.es/inebase/cgi/um

  7. Población según el sexo por edad (grupos quinquenales) 1999. Instituto Nacional de Estadística. España. http://www.ine.es/inebase/cgi/um

  8. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland P. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men an women. JAMA 1999;282:2012-8.

  9. Fuster V. Epidemic of Cardiovascular Disease and Stroke: The Three Main Challenges. Circulation. 1999;99:1132-1137.

  10. 10.Reddy KS & Yusuf S. Emerging Epidemic of Cardiovascular Disease in Developing Countries. Circulation 1998;97:596-601.

  11. 11.Morales-Ramírez JJ, Angulo PB, Rosas AC, Beauroyre HR, Corro SMA. Hacia la prevención de la enfermedades cardiovasculares y de la hipertensión arterial. A partir de la epidemiología de la hipertensión sistólica aislada. Rev Esp Med Quir 2003;8:

  12. 12.Morales-Ramírez JJ, Angulo PB, Rosas AC, Beauroyre HR, Corro SMA. Hacia la prevención de la enfermedades cardiovasculares y de la hipertensión arterial. A partir de la epidemiología de la hipertensión sistólica y diastólica. Rev Esp Med Quir 2003;8:

  13. 13.National Institutes of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. The evidence report. NIH Publication Nº 98-4083. 1998, Betesda,MD p xiv

  14. 14.Hosmer DW & Lemeshow S. Applied Logistic Regresion. John Wiley & Sons New York 1989.

  15. 15.Velázquez MO, Rosas PM, Lara EA, Pastelín HG, Atie F, Tapia CR. Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2002;72:71-84.

  16. 16.Blank SG, Mann SJ, James GD,. West JE, Pickering TG. Isolated Elevation of Diastolic Blood Pressure. Real or Artifactual? Hypertension. 1995;26:383-389.

  17. 17.Vázquez VE, García de alba C, Merino AED, Parra CJZ. Algnos aspectos de la presión arterial en el área rural de Jalisco, parte II. Sal Publ Mex 1981;23:83-92.

  18. 18.Arroyo P, Fernandez V, Avila-Rosas H. Overweight and Hypertension. Data From the 1992-1993 Mexican Survey. Hypertension. 1997;30:646

  19. 19.Fang J; Madhavan S, Cohen H, Alderman MH. Isolated Diastolic Hypertension. A Favorable Finding Among Young and Middle-aged Hypertensive Subjects. Hypertension. 1995;26:377-382.




2020     |     www.medigraphic.com